The story has been updated to include commments from Danaher's conference call.

NEW YORK (GenomeWeb News) – Danaher today reported that its sales in the first quarter increased 3 percent year over year, while sales in the Life Science and Diagnostics segment inched up 1 percent.

The company recorded companywide sales of $4.44 billion, up from $4.32 billion in the first quarter of 2012, but short of the average Wall Street estimate of $4.50 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.